Ensitrelvir is effective against SARS-CoV-2 3CL protease mutants circulating globally. Kawashima S, Matsui Y, Adachi T, Morikawa Y, et al. Biochem Biophys Res Commun 2023;645:132-136.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kawashima S, Matsui Y, Adachi T, Morikawa Y, et al. Ensitrelvir is effective against SARS-CoV-2 3CL protease mutants circulating globally. Biochem Biophys Res Commun 2023;645:132-136.
PMID: 36689809